Pharmacies advised to ‘carefully consider’ FMD verification systems

Community pharmacies must work towards compliance with the Falsified Medicines Directive (FMD) in time for the February 9 deadline irrespective of any Brexit scenario, pharmacy bodies have said.

The guidance, from the UK FMD Working Group for Community Pharmacy, follows recent meetings between the regulators, the government and the Working Group itself.

Medicines and Healthcare products Regulatory Agency has earlier confirmed that FMD regulations won’t apply in the event of a ‘no-deal’ Brexit.  

“Nevertheless, pharmacies must make efforts to be compliant with the new FMD safety features, by the deadline. Pharmacies must act promptly, but they must also act properly to ensure they are prepared for the new FMD safety features,” said Raj Patel, chair of the Working Group.

“They must carefully consider the terms of any contract for FMD solutions and make sure they are futureproof in any post-Brexit scenario.”  

The safety features regulation under FMD requires medicines packaging to have a unique 2D-barcode and an anti-tampering device, both of which must be checked at various points in the supply chain.

“All parties recognise the challenges around FMD and we are confident that the regulators will take a pragmatic and even-handed approach to enforcement,” Patel added.

“Other practical adjustments might be required, such as modifying dispensing workflows and all pharmacies will need to update their standard operating procedures.

“However, there will be very few packs of medicines in pharmacies with the FMD safety features, on February 9, as they will take time to come through the medicines supply chain, so inevitably the sector is on a journey towards full implementation.”

From February 9, pharmacies must check the integrity of the anti-tampering device and scan the 2D barcode to mark each pack as decommissioned (or dispensed) in the FMD database.

It is understood there will be significant quantities of medicines in the supply chain that do not carry the new safety features, after February 9, but it can still be wholesaled and dispensed, noted a statement from the Working Group.  

If you want to share your stories and/or experiences with us, please send an email to [email protected]